# KOVANAZE
> **NDA208032** · New Drug Application · Sponsor: ST RENATUS · Approved 2016-06-29
## Drug
- **FDA Application Number:** NDA208032
- **Application type:** New Drug Application
- **Brand name:** KOVANAZE
- **Generic name:** Oxymetazoline Hydrochloride
- **Active ingredients:** OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** ST RENATUS
- **First approval:** 2016-06-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208032)
---
*MORVS · CC0 1.0*